Researchers from Texas A&M University’s College of Veterinary Medicine and Biomedical Sciences and the University of Minnesota have received a $3.8 million grant from the National Institutes of Health to develop antiviral treatments for mpox, formerly known as monkeypox. The disease, which causes rashes and blisters, remains a significant public health concern in parts of Central and Eastern Africa, where it is endemic
Home
—
Global Center for Health Security
—
The Transmission
—
Texas A&M, University of Minnesota receive $3.8M for Mpox treatment research
Texas A&M, University of Minnesota receive $3.8M for Mpox treatment research
- Published Jan 22, 2025